Brown Advisory Inc. Has $200.15 Million Stock Position in HealthEquity, Inc. (NASDAQ:HQY)

Brown Advisory Inc. raised its position in HealthEquity, Inc. (NASDAQ:HQY - Free Report) by 12.0% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 2,086,026 shares of the company's stock after purchasing an additional 224,016 shares during the quarter. Brown Advisory Inc. owned about 2.41% of HealthEquity worth $200,154,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds and other institutional investors have also made changes to their positions in the business. Arcadia Investment Management Corp MI bought a new position in shares of HealthEquity in the fourth quarter valued at approximately $26,000. Transce3nd LLC bought a new position in HealthEquity during the 4th quarter valued at $29,000. Smartleaf Asset Management LLC increased its position in shares of HealthEquity by 34.3% during the 4th quarter. Smartleaf Asset Management LLC now owns 384 shares of the company's stock valued at $37,000 after purchasing an additional 98 shares during the period. Proficio Capital Partners LLC bought a new stake in shares of HealthEquity in the 4th quarter worth $39,000. Finally, UMB Bank n.a. lifted its holdings in shares of HealthEquity by 65.6% in the fourth quarter. UMB Bank n.a. now owns 414 shares of the company's stock valued at $40,000 after buying an additional 164 shares during the period. 99.55% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling

In related news, EVP Michael Henry Fiore sold 8,881 shares of HealthEquity stock in a transaction on Friday, April 4th. The stock was sold at an average price of $78.26, for a total transaction of $695,027.06. Following the completion of the sale, the executive vice president now owns 56,655 shares of the company's stock, valued at approximately $4,433,820.30. This trade represents a 13.55 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Robert W. Selander sold 5,750 shares of the company's stock in a transaction dated Monday, February 10th. The stock was sold at an average price of $111.29, for a total value of $639,917.50. Following the completion of the transaction, the director now directly owns 78,219 shares in the company, valued at approximately $8,704,992.51. The trade was a 6.85 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders sold 20,381 shares of company stock valued at $1,781,432. Corporate insiders own 2.20% of the company's stock.

Wall Street Analyst Weigh In

HQY has been the topic of a number of research analyst reports. Wells Fargo & Company lifted their target price on HealthEquity from $110.00 to $125.00 and gave the stock an "overweight" rating in a report on Wednesday, February 26th. KeyCorp lowered their price objective on shares of HealthEquity from $110.00 to $100.00 and set an "overweight" rating on the stock in a research note on Wednesday, April 16th. Barrington Research restated an "outperform" rating and set a $112.00 target price on shares of HealthEquity in a report on Friday, April 11th. Raymond James upgraded shares of HealthEquity from an "outperform" rating to a "strong-buy" rating and decreased their price target for the stock from $120.00 to $115.00 in a research report on Tuesday, March 25th. Finally, The Goldman Sachs Group cut their price objective on HealthEquity from $107.00 to $94.00 and set a "neutral" rating for the company in a research report on Thursday, March 27th. One investment analyst has rated the stock with a hold rating, ten have assigned a buy rating and one has issued a strong buy rating to the company's stock. According to MarketBeat, the company currently has a consensus rating of "Buy" and a consensus target price of $111.75.

HealthEquity Stock Up 1.8 %

Shares of HealthEquity stock traded up $1.61 during midday trading on Wednesday, hitting $91.75. The company's stock had a trading volume of 825,427 shares, compared to its average volume of 785,163. HealthEquity, Inc. has a 1-year low of $65.01 and a 1-year high of $115.59. The company has a quick ratio of 3.20, a current ratio of 3.20 and a debt-to-equity ratio of 0.51. The firm has a market capitalization of $7.94 billion, a P/E ratio of 84.17, a PEG ratio of 1.60 and a beta of 0.45. The stock has a 50-day simple moving average of $88.57 and a 200-day simple moving average of $96.58.

HealthEquity Company Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.